Monoprost (Latanoprost)

Latanoprost binds to FP receptors in the ciliary body, remodeling extracellular matrix and enhancing uveoscleral outflow of aqueous humor. This increased outflow reduces intra‑ocular pressure, which is the primary therapeutic goal in glaucoma and ocular hypertension.

The prescribed dose of Monoprost is determined by the treating ophthalmologist. Typically, one drop is instilled in the affected eye(s) once daily in the evening, but the exact regimen should follow the prescriber’s instructions.

Safety data for latanoprost in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the prescriber should evaluate each case individually.

To place an order, submit an enquiry on the Monoprost product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Monoprost is a prostaglandin analog, generally offering once‑daily dosing and a favorable IOP‑lowering profile compared with beta‑blocker or carbonic anhydrase inhibitor drops. Its side‑effect profile includes characteristic iris darkening and eyelash growth, which differ from the systemic effects sometimes seen with other classes.

Monoprost should be stored at room temperature, below 25 °C, in its original packaging. Keep the bottle away from direct sunlight and moisture, and discard any solution that appears discolored or contaminated.

Monoprost is administered as an ophthalmic solution. The patient should wash hands, tilt the head back, pull down the lower eyelid, and place a single drop into the conjunctival sac of the affected eye(s). Close the eye gently for a few seconds and avoid blinking excessively.

Serious but rare risks include severe allergic reactions, uveitis, macular edema, paradoxical increase in intra‑ocular pressure, and corneal edema. Patients should seek immediate medical attention if they experience sudden vision changes, eye pain, or signs of an allergic response.

Monoprost is contraindicated in patients with active ocular infection or inflammation, and it should be used with caution in individuals with a history of hypersensitivity to latanoprost or any component of the formulation. Pregnant or nursing women should only use it if clearly needed and prescribed by a specialist.